Trial intelligence / Profile preview

SABINA: Probiotics in Acute Gastroenteritis

NCT03539913Phase 4Completed

Sponsor
Biocodex
Start
Jun 2017
Primary completion
Jun 2018
Modality
Microbiome Therapeutics
Countries
1
01

Overview

A Phase 4 trial of saccharomyces boulardii in acute gastroenteritis, sponsored by Biocodex. Started Jun 2017; status: completed.

02

Drugs

saccharomyces boulardii
03

Conditions

acute gastroenteritis

Beyond the preview

Go deeper on NCT03539913.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03539913.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call